• Abrysvo powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, F PROTEIN SUBUNIT 847A STABILIZED IN PREFUSION	0,06 mg
  RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP B, F PROTEIN SUBUNIT 847B STABILIZED IN PREFUSION	0,06 mg

  ATC: J07B J07BX J07BX05

• Benefix 1000 IU, powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  NONACOG ALFA	1000 UI

  ATC: B02B B02BD B02BD04

• Benefix 2000 IU, powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  NONACOG ALFA	2000 UI

  ATC: B02B B02BD B02BD04

• Benefix 250 UI, powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  NONACOG ALFA	250 UI

  ATC: B02B B02BD B02BD04

• Benefix 3000 IU, powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  NONACOG ALFA	3000 UI

  ATC: B02B B02BD B02BD04

• Benefix 500 IU, powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  NONACOG ALFA	500 UI

  ATC: B02B B02BD B02BD04

• Besponsa 1 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  INOTUZUMAB OZOGAMICIN	1 mg

  ATC: L01F L01FB L01FB01

• Bosulif 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BOSUTINIB MONOHYDRATE	100 mg

  ATC: L01E L01EA L01EA04

• Bosulif 100 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  BOSUTINIB MONOHYDRATE	103,40 mg

  ATC: L01E L01EA L01EA04

• Bosulif 400 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BOSUTINIB MONOHYDRATE	413,6 mg

  ATC: L01E L01EA L01EA04

• Bosulif 50 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  BOSUTINIB MONOHYDRATE	51,70 mg

  ATC: L01E L01EA L01EA04

• Bosulif 500 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BOSUTINIB MONOHYDRATE	500 mg

  ATC: L01E L01EA L01EA04

• Champix 0.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  VARENICLINE	0,5 mg

  ATC: N07B N07BA N07BA03

• Champix 0.5 mg, 1 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  VARENICLINE	0,5 mg

  ATC: N07B N07BA N07BA03

• Champix 1 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  VARENICLINE	1 mg

  ATC: N07B N07BA N07BA03

• Cibinqo 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ABROCITINIB	100 mg

  ATC: D11A D11AH D11AH08

• Cibinqo 200 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ABROCITINIB	200 mg

  ATC: D11A D11AH D11AH08

• Cibinqo 50 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ABROCITINIB	50 mg

  ATC: D11A D11AH D11AH08

• Conbriza 20 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BAZEDOXIFENO ACETATO	20 mg

  ATC: G03X G03XC G03XC02

• Duavive 0.45 mg/20 mg modified-release tablets

  Form: tablets, modified release

  Active substance	Dosage
  CONJUGATED ESTROGENS	0,45 mg
  BAZEDOXIFENO ACETATO	20 mg

  ATC: G03C G03CC G03CC07

• Dynastat 40 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  PARECOXIB	40 mg

  ATC: M01A M01AH M01AH04

• Dynastat 40 mg powder for solution for injection

  Form: powder for solution for injection

  Active substance	Dosage
  PARECOXIB	40 mg

  ATC: M01A M01AH M01AH04

• Ecalta 100 mg powder for concentrate for infusion solution

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  ANIDULAFUNGINA	100 mg

  ATC: J02A J02AX J02AX06

• Elrexfio 40 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  ELRANATAMAB	40 mg

  ATC: L01F L01FX L01FX32

• Emblaveo 1.5 g/0.5 g powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  AVIBACTAM SODIUM	542 mg
  AZTREONAM	1500 mg

  ATC: J01D J01DF J01DF51

• Enbrel 10 mg powder and solvent for solution for injection for pediatric use

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  ETANERCEPT	10 mg

  ATC: L04A L04AB L04AB01

• Enbrel 25 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  ETANERCEPT	25 mg

  ATC: L04A L04AB L04AB01

• Enbrel 25 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  ETANERCEPT	23.50 mg

  ATC: L04A L04AB L04AB01

• Enbrel 25 mg solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  ETANERCEPT	25 mg

  ATC: L04A L04AB L04AB01

• Enbrel 50 mg solution for injection in pre-filled pens

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  ETANERCEPT	50 mg

  ATC: L04A L04AB L04AB01

• Enbrel 50 mg solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  ETANERCEPT	50 mg

  ATC: L04A L04AB L04AB01

• Hympavzi 150 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  MARSTACIMAB	150 mg

  ATC: B02B B02BX B02BX11

• Ibrance 100 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  PALBOCICLIB	100 mg

  ATC: L01E L01EF L01EF01

• Ibrance 125 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  PALBOCICLIB	125 mg

  ATC: L01E L01EF L01EF01

• Ibrance 75 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  PALBOCICLIB	75 mg

  ATC: L01E L01EF L01EF01

• Inlyta 1 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  AXITINIB	1,00 mg

  ATC: L01E L01EK L01EK01

• Inlyta 5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  AXITINIB	5,00 mg

  ATC: L01E L01EK L01EK01

• Litfulo 50 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  Ritlecitinib Tosylate	80,12 mg

  ATC: L04A L04AF L04AF08

• Lorviqua 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  LORLATINIB	100 mg

  ATC: L01E L01ED L01ED05

• Lorviqua 25 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  LORLATINIB	25 mg

  ATC: L01E L01ED L01ED05

• Mylotarg 5 mg powder for concentrate for solution for infusion

  Form: powder for concentrate and solution for infusion

  Active substance	Dosage
  GEMTUZUMAB OZOGAMICINE	5 mg

  ATC: L01F L01FX L01FX02

• Ngenla 24 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  SOMATROGON	24 mg

  ATC: H01A H01AC H01AC08

• Ngenla 60 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  SOMATROGON	60 mg

  ATC: H01A H01AC H01AC08

• Nimenrix powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A	5 µg
  MENINGOCOCCAL GROUP C POLYSACCHARIDE ANTIGEN	5 µg
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135	5 µg
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y	5 µg

  ATC: J07A J07AH J07AH08

• Nimenrix powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A	5 µg
  MENINGOCOCCAL GROUP C POLYSACCHARIDE ANTIGEN	5 µg
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135	5 µg
  MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y	5 µg

  ATC: J07A J07AH J07AH08

• Nivestim 12 MU/0.2 ml solution for injection or for infusion

  Form: solution for injection and for infusion

  Active substance	Dosage
  FILGRASTIM	0,120 mg

  ATC: L03A L03AA L03AA02

• Nivestim 12 MU/0.2 ml solution for injection or for infusion

  Form: solution for injection and infusion in pre-filled syringe

  Active substance	Dosage
  FILGRASTIM	12 MILLONES UI

  ATC: L03A L03AA L03AA02

• Nivestim 30 MU/0.5 ml solution for injection and infusion

  Form: solution for injection and for infusion

  Active substance	Dosage
  FILGRASTIM	0,300 mg

  ATC: L03A L03AA L03AA02

• Nivestim 30 MU/0.5 ml solution for injection and infusion

  Form: solution for injection and infusion in pre-filled syringe

  Active substance	Dosage
  FILGRASTIM	30 MILLONES UI

  ATC: L03A L03AA L03AA02

• Nivestim 48 MU/0.5 ml solution for injection or for infusion

  Form: solution for injection and for infusion

  Active substance	Dosage
  FILGRASTIM	48 UI

  ATC: L03A L03AA L03AA02